Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-7.4%
5Y CAGR+8.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.4%/yr
vs +25.4%/yr prior
5Y CAGR
+8.4%/yr
Recent deceleration
Acceleration
-32.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.88M | -55.8% |
| 2024 | $51.78M | +32.9% |
| 2023 | $38.96M | +35.2% |
| 2022 | $28.81M | +19.4% |
| 2021 | $24.13M | +57.8% |
| 2020 | $15.29M | +9.3% |
| 2019 | $13.99M | +20.0% |
| 2018 | $11.66M | -14.3% |
| 2017 | $13.60M | +43.9% |
| 2016 | $9.45M | - |